- Platform
- Platform Overview
- Life science compliance
- Enterprise-grade security
- Integrations
- Partner Ecosystem
- Workflow management
- Claims & evidence management
- Digital asset management
- Web annotation
- Health authority submission support
- Portals
- Cross channel publishing
- Global commercialization
- Vodori 360
- Reporting & analytics
- Solutions
- Resources
- Company
- Trust
International pharmaceutical executive brings 25+ years of commercial leadership to support Vodori’s growth across EMEA and global life sciences
CHICAGO, IL – September 24, 2026 – Vodori, creator of the Regulated Content Intelligence Platform™, today announced the appointment of Becki Morison, CEO of Essential Pharma, to its Board of Directors. Morison joined the Board in August 2026.
Morison currently serves as CEO of Essential Pharma, a global pharmaceutical company focused on developing and delivering medicines for small, underserved, and rare-disease patient populations. She brings more than 25 years of international pharmaceutical leadership spanning commercial strategy, organizational transformation, medical affairs, pricing and market access, and affiliate operations. Her experience across pharmaceutical companies of varying sizes and stages will help guide Vodori’s continued global expansion and strengthen its ability to serve organizations ranging from emerging biopharma and generics companies to mature enterprise manufacturers.
“Becki brings a deep understanding of the commercial and operational challenges facing pharmaceutical companies across markets and stages of growth,” said Scott Rovegno, CEO and co-founder of Vodori. “Based in London, she will work closely with Ross Grey, Vodori’s VP and GM for EMEA, to support our continued expansion across Europe.”
“Her experience leading global pharmaceutical businesses will strengthen how we serve customers operating across different business models, regulatory environments, and levels of scale,” said Grey.
“Regulated content plays a critical role in how life sciences companies communicate with all stakeholders, yet the systems and processes behind it are often opaque and unnecessarily bloated,” said Morison. “Vodori has the industry expertise, technology, and customer focus to help industry operate with greater speed, consistency, intelligence, and confidence. I am pleased to join the Board and contribute to a company solving such an important challenge.”
About Vodori
Vodori helps life sciences organizations create, review, approve, and activate compliant content through an AI-powered platform purpose-built for life science teams. Building on more than 20 years of MLR expertise, Vodori is evolving that foundation through the creation of the Regulated Content Intelligence Platform™ (RCIP), the first enterprise software category purpose-built to operationalize governed knowledge across the regulated content lifecycle.
Media contact
Annalise Ludtke
Director of Marketing
Vodori
269.808.0012
annalise.ludtke@vodori.com
Other posts you might be interested in
View All Posts
3 min read
|
Vodori Announces Appointment of James Hussey to its Board of Directors | Vodori
Read More
2 min read
|
Vodori Announces Appointment of Lesly Marban to its Board of Advisors
Read More
3 min read
|
Vodori raises $3M to Expand its Suite of Next Generation Life Science Software | Vodori
Read MoreSubscribe to Vodori
We'll send you content and resources on MLR best practices, collaboration tips, and more. By subscribing, you consent to allow Vodori to store and process the personal information submitted to receive communications from Vodori. You may unsubscribe at any time. For more information, review our Privacy Policy.

